Table 3 Adverse events during follow-up in patients with true myocardial infarctions and coronaries without obstructive lesions
Adverse events, n (%) | All patients | 1 segment | 2 segments | ≥ 3 segments |
|---|---|---|---|---|
MACEs | 43 (35.8) | 8 (20) | 19 (44.2) | 16 (44.4) |
Non-fatal myocardial infarction | 7 (5.8) | 0 (0) | 3 (7) | 4 (11.1) |
Ischemic stroke | 4 (3.3) | 1 (2.5) | 1(2.3) | 2 (5.6) |
All-cause mortality | 9 (7.5) | 4 (10) | 3 (7) | 2 (5.6) |
Cardiovascular death | 2 (1.7) | 1 (2.5) | 0 (0) | 1 (2.8) |
Cardiovascular readmissions | 22 (18.3) | 3 (7.5) | 12 (27.9) | 8 (22.2) |
Atrial fibrillation (all) | 37 (30.8) | 9 (22.5) | 18 (41.9) | 10 (27) |